Microplastics and Misinformation: What Science Really Says
November 12, 2025
Brand Name :
Symlinpen 120, Symlinpen 60
Synonyms :
pramlintide
Class :
Amylinomimetic and Antidiabetic agent
Dosage Forms & Strengths
Solution Pen-injector, Subcutaneous:
1500 mcg/1.5ml
2700 mcg/2.7ml
Note: Reduce current insulin dose to 50% before initiating pramlintide to avoid hypoglycemia.
Subcutaneous injection of 15 mcg immediately before each meal
Subcutaneous injection of 60 mcg immediately before each meal
No safe and efficacious dose described
Refer to adult dosing
may enhance the activity of each other
may enhance the activity of each other
may enhance the activity of each other
may enhance the activity of each other
may enhance the activity of each other
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic agents
they increase the toxicity of each other due to pharmacodynamic synergism
pramlintide and dicyclomine increase the effect of each other through a synergistic activity
pramlintide with meclizine increase the effect of each other by synergism
pramlintide and miglitol increase the effect of each other due to synergism
pramlintide and acarbose increase the effect of each other due to synergism
may increase the pharmacodynamic synergism
may increase the anticholinergic effect of anticholinergic agents
may increase the anticholinergic effect of Anticholinergic Agents
may increase the hypoglycaemic effect
may increase the hypoglycaemic effect
methylprednisolone hemisuccinate
When methylprednisolone hemisuccinate is aided with pramlintide, this leads to elevated hyperglycemia risk
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
may increase the hypoglycemic effect
may increase the hypoglycemic effect
the anti-diabetic efficacy of acarbose can be reduced with pramlintide furoate
Frequency defined:
>10%:
Headache
Severe hypoglycemia
Nausea
Anorexia
Vomiting
Accidental injury
1% to 10%:
Fatigue
Abdominal pain
Cough
Pharyngitis
Pancreatitis
Arthralgia
Pregnancy consideration: pramlintide is currently not recommended for treatment of diabetes mellitus in pregnant women.
Lactation: excretion of pramlintide in breast milk is not known.
Pregnancy category:
Patient information leaflet
Generic Name: Pramlintide
Pronounced: pramlintide
Why do we use pramlintide?
Pramlintide is used for the treatment of diabetes mellitus type 1 and type 2.